J. Bruijn

发表

Autonomic neurocardiac regulation in major depressive disorder

J. Tulen, J. Passchier, A. Volkers, 2000, European Neuropsychopharmacology.

Motor activity and autonomic cardiac functioning in major depressive disorder.

Jan Passchier, J. Passchier, A. Volkers, 2003, Journal of affective disorders.

Double-blind Placebo Controlled Study of the Effects of Etomidate-Alfentanil Anesthesia in Electroconvulsive Therapy

P. Mulder, J. Bruijn, W. W. van den Broek, 2004, The journal of ECT.

Anxiety and autonomic regulation in major depressive disorder: an exploratory study.

A. J. Man in 't Veld, J. Tulen, L. Pepplinkhuizen, 1996, Journal of affective disorders.

The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patients

J. Lindemans, A. Vulto, R. Mathôt, 2010, The Pharmacogenomics Journal.

Association of graded allele-specific changes in CYP2D6 function with imipramine dose requirement in a large group of depressed patients

J. Lindemans, A. Vulto, R. Mathôt, 2008, Molecular Psychiatry.

Immunoglobulin production in vitro in major depression: A pilot study on the modulating action of endogenous cortisol

H. Westenberg, J. M. Ree, C. Heijnen, 1995, Biological Psychiatry.

Trait anxiety and the effect of a single high dose of diazepam in unipolar depression.

P. Moleman, P. Mulder, P. Mulder, 2001, Journal of psychiatric research.

A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients.

P. Mulder, T. Birkenhäger, J. Bruijn, 2013, Journal of psychiatric research.

Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial.

P. Moleman, P. Mulder, T. Birkenhäger, 2006, The Journal of clinical psychiatry.

Lithium addition in antidepressant-resistant depression: Effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration

D. Fekkes, P. Moleman, P. Mulder, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study.

A. Leentjens, P. Mulder, J. Bruijn, 1999, British journal of anaesthesia.

Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression

D. Fekkes, L. Pepplinkhuizen, W. V. D. Broek, 2001, Psychiatry Research.

Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed?

A. Vulto, P. Moleman, T. Birkenhäger, 2005, Psychopharmacology.

Alfentanil has no proconvulsive effect during electro convulsive therapy

P. Mulder, W. V. D. Broek, J. Bruijn, 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Beta-Blocking Agents and Electroconvulsive Therapy

P. Mulder, T. Birkenhäger, W. V. D. Broek, 2007 .

CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine.

J. Passchier, A. Volkers, J. Tulen, 2002, Journal of psychiatric research.

24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder

Jan Passchier, J. Passchier, A. Volkers, 2002, European Neuropsychopharmacology.

Efficacy of Imipramine in Psychotic Versus Nonpsychotic Depression

P. Moleman, P. Mulder, T. Birkenhager, 2008, Journal of clinical psychopharmacology.

Treatment of unipolar psychotic depression: a randomized, double‐blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine

W A Nolen, J Wijkstra, W. Nolen, 2010, Acta psychiatrica Scandinavica.

Time-dependent clearance decrements of fluvoxamine in depressed inpatients: a clinical evaluation.

R. Mathôt, P. Moleman, P. Mulder, 2007, Journal of clinical psychopharmacology.

Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.

P. Moleman, P. Mulder, T. Birkenhäger, 2004, The American journal of psychiatry.

Genetic variants in pre-eclampsia: a meta-analysis.

O. Dekkers, J. Schoones, H. Baelde, 2013, Human reproduction update.

Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis.

P. Mulder, H. V. van Buuren, J. Bruijn, 2007, Journal of hepatology.

A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients

P. Moleman, P. Mulder, R. Mast, 1996, Psychopharmacology.

Effect of Antidepressant Medication Resistance on Short-term Response to Electroconvulsive Therapy

P. Mulder, T. Birkenhäger, J. Bruijn, 2004, Journal of clinical psychopharmacology.

[A successful treatment of drug-resistant depression with electroconvulsive therapy].

J. Bruijn, W. W. van den Broek, M. Gieteling, 1998, Nederlandsch tijdschrift voor geneeskunde.

Long-term response to successful acute pharmacological treatment of psychotic depression.

W. Nolen, R. Verkes, J. Janzing, 2010, Journal of affective disorders.

Treatment of unipolar psychotic depression: an open study of lithium addition in refractory psychotic depression.

W. Nolen, M. Boks, R. Verkes, 2009, Journal of clinical psychopharmacology.

Reply to Dr Baldessarini's comments on "efficacy of imipramine in psychotic versus nonpsychotic depression"

P. Moleman, T. Birkenhäger, W. V. D. Broek, 2008 .

Genetic Variants in Pre-Eclampsia: A Meta-Analysis

O. Dekkers, J. Schoones, H. Baelde, 2013 .

Cardiovascular variability in major depressive disorder and effects of imipramine or mirtazapine (Org 3770).

A. J. Man in 't Veld, J. Tulen, A. H. van den Meiracker, 1996, Journal of clinical psychopharmacology.

Comparison of 2 treatment strategies for depressed inpatients: imipramine and lithium addition or mirtazapine and lithium addition.

P. Moleman, P. Mulder, J. Bruijn, 1998, The Journal of clinical psychiatry.

Depressed In-Patients Respond Differently to Imipramine and Mirtazapine

P. Moleman, P. Mulder, J. Bruijn, 1999, Pharmacopsychiatry.

Outcome of a 4-step treatment algorithm for depressed inpatients.

P. Moleman, T. Birkenhäger, J. Bruijn, 2006, The Journal of clinical psychiatry.

"New" better than "old"? : detection of differences in efficacy between treatments in depressed inpatients under optimal conditions

J. Bruijn, 2001 .

Treatment of unipolar psychotic depression: an open study of lithium addition in refractory psychotic depression.

W. Nolen, R. Verkes, J. Janzing, 2009, Journal of clinical psychopharmacology.

Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.

A. Volkers, J. Tulen, J. Bruijn, 2006, Journal of clinical psychopharmacology.

Trait Anxiety and Defensive Functioning in Relation to Antidepressant Treatment Outcome

P. Mulder, T. Birkenhäger, J. Bruijn, 2009, Psychopathology.

A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients

P. Moleman, P. Mulder, T. Birkenhäger, 2004, Psychopharmacology.

Treatment of mood-congruent psychotic depression with imipramine.

P. Moleman, J. Bruijn, P. Mulder, 2001, Journal of affective disorders.

A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients

B. V. D. van de Wetering, P. Moleman, A. V. van Hulst, 2008, Psychopharmacology.

Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.

P. Moleman, P. Mulder, T. Birkenhäger, 2004, The Journal of clinical psychiatry.